Literature DB >> 11381117

Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.

M H Heemskerk1, R A de Paus, E G Lurvink, F Koning, A Mulder, R Willemze, J J van Rood, J H Falkenburg.   

Abstract

The alloreactive human T cell clone MBM15 was found to exhibit dual specificity recognizing both an antigen in the context of the HLA class I A2 molecule and an antigen in the context of the HLA class II DR1. We demonstrated that the dual reactivity that was mediated via a single clonal T cell population depended on specific peptide binding. For complete recognition of the HLA-A2-restricted specificity the interaction of CD8 with HLA class I is essential. Interestingly, interaction of the CD8 molecule with HLA class I contributed to the HLA-DR1-restricted specificity. T cell clone MBM15 expressed two in-frame T cell receptor (TCR) Valpha transcripts (Valpha1 and Valpha2) and one TCR Vbeta transcript (Vbeta13). To elucidate whether two TCR complexes were responsible for the dual recognition or one complex, cytotoxic T cells were transduced with retroviral vectors encoding the different TCR chains. Only T cells transduced with the TCR Valpha1Vbeta13 combination specifically recognized both the HLA-A2(+) and HLA-DR1(+) target cells, whereas the Valpha2Vbeta13 combination did not result in a TCR on the cell surface. Thus a single TCRalphabeta complex can have dual specificity, recognizing both a peptide in the context of HLA class I as well as a peptide in the context of HLA class II. Transactivation of T cells by an unrelated antigen in the context of HLA class II may evoke an HLA class I-specific T cell response. We propose that this finding may have major implications for immunotherapeutic interventions and insight into the development of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381117      PMCID: PMC34434          DOI: 10.1073/pnas.111162298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.

Authors:  W Wang; S Man; P H Gulden; D F Hunt; V H Engelhard
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

2.  Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.

Authors:  M K Teng; A Smolyar; A G Tse; J H Liu; J Liu; R E Hussey; S G Nathenson; H C Chang; E L Reinherz; J H Wang
Journal:  Curr Biol       Date:  1998-03-26       Impact factor: 10.834

3.  Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides.

Authors:  K D Smith; E Huczko; V H Engelhard; Y Y Li; C T Lutz
Journal:  Transplantation       Date:  1997-07-27       Impact factor: 4.939

4.  Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52.

Authors:  F A Verreck; A van de Poel; J W Drijfhout; R Amons; J E Coligan; F Konig
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

5.  Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.

Authors:  K Udaka; K H Wiesmüller; S Kienle; G Jung; P Walden
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

6.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells.

Authors:  H Hanenberg; X L Xiao; D Dilloo; K Hashino; I Kato; D A Williams
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity.

Authors:  M D Tallquist; T J Yun; L R Pease
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

8.  Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer.

Authors:  L Ruggieri; A Aiuti; M Salomoni; E Zappone; G Ferrari; C Bordignon
Journal:  Hum Gene Ther       Date:  1997-09-01       Impact factor: 5.695

9.  Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry.

Authors:  R Zhao; D J Loftus; E Appella; E J Collins
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.

Authors:  M H Heemskerk; B Blom; G Nolan; A P Stegmann; A Q Bakker; K Weijer; P C Res; H Spits
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  23 in total

1.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.

Authors:  Willemijn Vader; Dariusz Stepniak; Yvonne Kooy; Luisa Mearin; Allan Thompson; Jon J van Rood; Liesbeth Spaenij; Frits Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

2.  Programming CMV for vaccine vector design.

Authors:  Srinika Ranasinghe; Bruce D Walker
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908

3.  PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.

Authors:  Gülçin Gezgin; Sietse J Luk; Jinfeng Cao; Mehmet Dogrusöz; Dirk M van der Steen; Renate S Hagedoorn; Daniëlle Krijgsman; Pieter A van der Velden; Matthew G Field; Gregorius P M Luyten; Karoly Szuhai; J William Harbour; Ekaterina S Jordanova; Mirjam H M Heemskerk; Martine J Jager
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

4.  The human leukocyte antigen-presented ligandome of B lymphocytes.

Authors:  Chopie Hassan; Michel G D Kester; Arnoud H de Ru; Pleun Hombrink; Jan Wouter Drijfhout; Harm Nijveen; Jack A M Leunissen; Mirjam H M Heemskerk; J H Frederik Falkenburg; Peter A van Veelen
Journal:  Mol Cell Proteomics       Date:  2013-03-12       Impact factor: 5.911

Review 5.  Class II-Restricted CD8s: New Lessons Violate Old Paradigms.

Authors:  Stephen A Migueles; Mark Connors
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

6.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

7.  A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques.

Authors:  Gaby G M Doxiadis; Nanine de Groot; Frans H J Claas; Ilias I N Doxiadis; Jon J van Rood; Ronald E Bontrop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

Review 8.  Tumor vaccines and beyond.

Authors:  Jan Joseph Melenhorst; Austin John Barrett
Journal:  Cytotherapy       Date:  2010-11-10       Impact factor: 5.414

Review 9.  Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains.

Authors:  Eric S Huseby; John W Kappler; Philippa Marrack
Journal:  Mol Immunol       Date:  2008-02       Impact factor: 4.407

Review 10.  Safety and Tolerability of Adoptive Cell Therapy in Cancer.

Authors:  Benita Wolf; Stefan Zimmermann; Caroline Arber; Melita Irving; Lionel Trueb; George Coukos
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.